Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection

Sandrine Aspeslagh1, Marek Nemčovič2, Nora Pauwels3

  • 1Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Insights

Researchers explored novel glycolipids to enhance NKT cell therapy. A new analog showed potent antitumor activity by forming unique interactions with the NKT cell receptor, boosting immune response.

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Natural Killer T (NKT) cells are regulatory T cells that recognize glycolipids via CD1d.
  • The interaction between NKT cell receptors (NKTCR) and glycolipids like α-galactosylceramide (α-GalCer) is more flexible than previously understood.

Purpose of the Study:

  • To analyze the structure-function relationship of novel 6''-OH analogs of α-GalCer.
  • To identify analogs with enhanced antitumor properties and understand their interaction with NKTCR.

Main Methods:

  • Synthesis and structural analysis of novel α-GalCer analogs.
  • Evaluation of glycolipid interactions with NKTCR.
  • Assessment of antitumor activity and Th1 polarization in vivo.

Main Results:

  • A novel carbamate analog, α-GalCer-6''-(pyridin-4-yl)carbamate, demonstrated potent antitumor characteristics.
  • This analog formed unique interactions with the NKTCR.
  • The novel interaction led to high Th1 polarization and superior antitumor responses.

Conclusions:

  • Adding aromatic moieties to the 6''-OH position of α-GalCer enhances antitumor properties.
  • Judicious linker selection can create potent Th1-polarizing glycolipids by improving CD1d or NKTCR binding.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...